Related Experiment Video
Updated: Feb 24, 2026

A Novel Feeder-free System for Mass Production of Murine Natural Killer Cells In Vitro
Published on: January 9, 2018
Refined Modulation of Natural Killer Cells by Transforming Growth Factor-β Isoforms
Kaku Goto1,2, Ryo Amano1, Yoshikazu Nakamura1,3
1Project Division of RNA Medical Science, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.
Transforming growth factor-beta 3 (TGF-β3) uniquely upregulates INAVA in natural killer (NK) cells, enhancing their cancer-fighting ability. This discovery offers new avenues for cancer immunotherapy by selectively targeting TGF-β isoforms.
Area of Science:
- Immunology
- Cancer Biology
- Molecular Biology
Background:
- Natural killer (NK) cells are crucial for anti-tumor immunity.
- The tumor microenvironment, particularly transforming growth factor-beta (TGF-β), suppresses NK cell activity.
- Distinct functions of TGF-β isoforms (TGF-β1, TGF-β2, TGF-β3) are increasingly recognized.
Purpose of the Study:
- To elucidate the specific effects of TGF-β isoforms on NK cells.
- To identify novel regulators of NK cell function modulated by TGF-β isoforms.
- To explore the therapeutic potential of selective TGF-β isoform modulation.
Main Methods:
- Genome-wide gene expression analysis to identify TGF-β isoform-specific targets.
- Investigated the effect of TGF-β3 on innate immunity activator (INAVA) expression.
- Assessed the impact of INAVA on interferon gamma (IFN-γ) signaling and NK cell cytotoxicity.
- Evaluated an anti-TGF-β1 aptamer's effect on INAVA upregulation.
- Analyzed clinical data correlating INAVA expression with tumor-infiltrating NK (TINK) cells and patient survival in melanoma.
Main Results:
- TGF-β3 uniquely upregulates INAVA in NK cells, distinct from TGF-β1 and TGF-β2.
- INAVA enhances IFN-γ signaling, boosting NK cell IFN-γ release and cytotoxicity against cancer cells.
- An anti-TGF-β1 aptamer preserved TGF-β3-mediated INAVA upregulation.
- Increased INAVA expression correlated with activated TINK cells and improved survival in melanoma patients.
Conclusions:
- TGF-β3 exerts a unique immunomodulatory function on NK cells via INAVA.
- Selective modulation of TGF-β isoforms, particularly TGF-β3, represents a promising immunotherapeutic strategy.
- Targeting the TGF-β3-INAVA pathway may enhance NK cell-based cancer therapies.
More Related Videos
06:55Measurement of Natural Killer Cell-Mediated Cytotoxicity and Migration in the Context of Hepatic Tumor Cells
Published on: February 22, 2020
09:54Assessment of Human Natural Killer Cell Events Driven by FcγRIIIa Engagement in the Presence of Therapeutic Antibodies
Published on: May 22, 2020
Related Concept Videos
TGF - β Signaling Pathway
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The...
Cells of the Innate Immune Response
Phagocytes
Phagocytes police the peripheral tissues by removing cellular debris and responding to the invasion of foreign substances or pathogens. Many phagocytes attack and remove microorganisms even before lymphocytes detect them. The human body has two general...
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
Cytotoxic T Cells-mediated Immune Response
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...